The delisting is the final step in the going-private transaction. Shareholders who tendered their shares have already received the $3.16 per share cash consideration plus CVRs. No further trading in ESPR common stock is expected. Monitor CVR milestone events for potential additional value.
Price Chart
Executive Summary
Esperion Therapeutics has been delisted from Nasdaq following its acquisition by ArchiMed (via Essence Parent Inc.) for $3.16 per share plus CVRs. The 25-NSE filing formalizes the removal of the company's common stock from listing and SEC registration, effective July 13, 2026. This is the final procedural step in the going-private transaction, and the stock will no longer trade on Nasdaq.
Key Facts
- Esperion Therapeutics completed its acquisition by ArchiMed (via Essence Parent Inc.) on July 13, 2026, for $3.16 per share in cash plus one CVR per share representing up to $100M in aggregate milestone payments.
- The 25-NSE filing formalizes the removal of Esperion's common stock from listing and registration on Nasdaq, effective July 13, 2026.
- The delisting follows a change of control, board replacement, and termination of the prior credit agreement with new debt financing from BioPharma Credit.
- The filing is made under Rule 17 CFR 240.12d2-2(a)(3), which covers securities that have been redeemed, retired, or matured.
Financial Impact
Shareholders received $3.16 per share in cash plus one CVR per share representing up to $100M in aggregate milestone payments. The stock will be delisted and no longer trade on Nasdaq.
Risk Factors
- CVR milestone payments are contingent and may not be achieved, resulting in no additional value beyond the $3.16 per share.
- The stock is now delisted and illiquid; remaining public shareholders must seek liquidity through the merger consideration process.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 25-NSE Filing (Primary) | 0001354457-26-000668 |
| Document: 0001354457-26-000668-index-headers.html | 0001354457-26-000668 |
| Document: 0001354457-26-000668-index.html | 0001354457-26-000668 |
| Document: 0001354457-26-000668.txt | 0001354457-26-000668 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 29d ago | Court Ruling | โ | awaiting T+5 | โ | โ |
Aug 13, 2026 7w ago | Institutional Cluster | โ | awaiting T+5 | โ | โ |
Jul 23, 2026 10w ago | 15-12G | โ | awaiting T+5 | โ | โ |
Jul 16, 2026 11w ago | EFFECT | $3.18 awaiting T+5 | awaiting T+5 | โ | โ |
Jul 16, 2026 11w ago | EFFECT | $3.18 awaiting T+5 | awaiting T+5 | โ | โ |
Jul 13, 2026 11w ago | 25-NSE | $3.19 awaiting T+5 | awaiting T+5 | โ | โ |
Jul 13, 2026 11w ago | 8-K | $3.19 awaiting T+5 | awaiting T+5 | โ | โ |
Jun 16, 2026 15w ago | DEFA14A | $3.17 $3.15 | โผ โ0.63% | โฒ +0.41% | โ |
Jun 11, 2026 16w ago | Institutional Cluster | $3.15 $3.17 | โฒ +0.63% | โฒ +0.20% | โ |
Jun 9, 2026 16w ago | 8-K | $3.14 $3.16 | โฒ +0.64% | โผ โ2.80% | โ |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access